Literature DB >> 29052423

Streamlined Total Synthesis of Trioxacarcins and Its Application to the Design, Synthesis, and Biological Evaluation of Analogues Thereof. Discovery of Simpler Designed and Potent Trioxacarcin Analogues.

K C Nicolaou1, Pengxi Chen1, Shugao Zhu1, Quan Cai1, Rohan D Erande1, Ruofan Li1, Hongbao Sun1, Kiran Kumar Pulukuri1, Stephan Rigol1, Monette Aujay2, Joseph Sandoval2, Julia Gavrilyuk2.   

Abstract

A streamlined total synthesis of the naturally occurring antitumor agents trioxacarcins is described, along with its application to the construction of a series of designed analogues of these complex natural products. Biological evaluation of the synthesized compounds revealed a number of highly potent, and yet structurally simpler, compounds that are effective against certain cancer cell lines, including a drug-resistant line. A novel one-step synthesis of anthraquinones and chloro anthraquinones from simple ketone precursors and phenylselenyl chloride is also described. The reported work, featuring novel chemistry and cascade reactions, has potential applications in cancer therapy, including targeted approaches as in antibody-drug conjugates.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29052423     DOI: 10.1021/jacs.7b08820

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  2 in total

Review 1.  Advances in the Asymmetric Total Synthesis of Natural Products Using Chiral Secondary Amine Catalyzed Reactions of α,β-Unsaturated Aldehydes.

Authors:  Zhonglei Wang
Journal:  Molecules       Date:  2019-09-19       Impact factor: 4.411

2.  Metabolomics Tools Assisting Classic Screening Methods in Discovering New Antibiotics from Mangrove Actinomycetia in Leizhou Peninsula.

Authors:  Qin-Pei Lu; Yong-Mei Huang; Shao-Wei Liu; Gang Wu; Qin Yang; Li-Fang Liu; Hai-Tao Zhang; Yi Qi; Ting Wang; Zhong-Ke Jiang; Jun-Jie Li; Hao Cai; Xiu-Jun Liu; Hui Luo; Cheng-Hang Sun
Journal:  Mar Drugs       Date:  2021-12-01       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.